In radiotherapy, the use of proton beams is one of the most promising
approaches in order to reduce the treatment volume and, consequently,
increase the total dose avoiding severe complications to the normal ti
ssues surrounding the target. Among the new hospital-based facilities
that are planned for the next future, the italian project is in an adv
anced stage of study. Because of the complexity and high cost of the i
talian centre, one of the most important information in order to estab
lish the cost/benefit balance, is represented by the number of potenti
al patients to be treated for the various pathologies. For this reason
it is useful to define a priority scale of clinical indications and,
on this basis, to estimate the yearly patient afflux to the center, ta
king into account the incidence and the expected new cases to be treat
ed with protons. Indications have been divided into two categories, ac
cording to decreasing priority. Category A includes all the tumors in
which the use of proton therapy has clearly demonstrated to be advanta
geous, being the only way to give a curative dose to the target. In It
aly, the extimated number of this category of patients is 825 each yea
r. Category B comprises a great variety of tumors characterized mainly
by a local evolution, with a limited likelihood of distant spread, an
d therefore potentially cured if the local control can be obtained. Th
e total number of potential patients in this category is more than 10,
000.